Chart Expert Says Merck (MRK) Has More Upside – Here’s Why

We recently published Top 10 Trending Stocks as Famous Billionaire Predicts Massive AI Stock Rally Before Bubble Burst. Merck & Co., Inc. (NYSE:MRK) is one of the trending stocks.

Carter Worth from Worth Charting said in a latest program on CNBC that Merck & Co Inc (NYSE:MRK) is one of the stocks that has more upside potential based on his analysis. Here is what the analyst said:

“The first is Merck & Co Inc (NYSE:MRK). This is the definition of a bearish to bullish reversal buy. 150 day is flattening. That’s how something bases and bottoms. Merck & Co Inc (NYSE:MRK) is up about 5% over the past 30 days.”

Asked how much more the stock can run, Worth said:

“This kind of bullish price volume correlation with very heavy volume is hard to stop day to day, week over week. So I would think at least 10 to 15% higher in these names and thematically for left for dead healthcare names.”

Impax US Sustainable Economy Fund stated the following regarding Merck & Co., Inc. (NYSE:MRK) in its second quarter 2025 investor letter:

“Merck & Co., Inc. (NYSE:MRK) (Health Care, Pharmaceuticals) has a high Corporate Resilience score, and is contributing to a more robust and sustainable health care system through its leading drug and vaccine discovery. The stock’s weakness in Q2 was driven by a combination of concerns about its drug pipeline, particularly the competition from generic versions of Keytruda, and weaker market sentiment around Health Care stocks.”

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.